First Patient Recruited to Promore Pharma's Clinical Trial Regarding Scarring According to Plan

STOCKHOLM, SWEDEN / ACCESSWIRE / February 16, 2022 / Promore Pharma (STO:PROMO)(FRA:8T0)STOCKHOLM, 16 February 2022 - Promore Pharma AB, a Swedish biopharmaceutical development company focusing on therapeutic peptides, announces that the first …